Vienna ImmunoLectures

After studying Medicine at the University of Genoa/Italy, Marta Rizzi completed her PhD in Clinical and Experimental Immunology in Genoa/Italy and San Diego/California in 2004. In 2007, she completed her residency training in Allergology and Clinical Immunology. After her Postdoc, she started her group in 2014 at the University Medical Center Freiburg. In 2014, she was awarded the prestigious Margarete von Wrangell fellowship. 

Since 2022 she is Professor of Clinical and Experimental Immunology at the Medical University of Vienna. 

She has been awarded the prestigious Heisenberg Professorship of the German Research foundation (DFG) and since 2023 she is also Professor for Experimental and Translational Rheumatology at the Faculty of Medicine of the University of Freiburg.

Marta Rizzi’s research focus is human B-lymphocytes development, maturation and activation in physiological and pathological conditions. She has developed unique expertise in in vitro modelling of early and late human B cell development.fter studying Medicine at the University of Genoa/Italy, Marta Rizzi completed her PhD in Clinical and Experimental Immunology in Genoa/Italy and San Diego/California in 2004. In 2007, she completed her residency training in Allergology and Clinical Immunology. After her Postdoc, she started her group in 2014 at the University Medical Center Freiburg. In 2014, she was awarded the prestigious Margarete von Wrangell fellowship. 

Since 2022 she is Professor of Clinical and Experimental Immunology at the Medical University of Vienna. 

She has been awarded the prestigious Heisenberg Professorship of the German Research foundation (DFG) and since 2023 she is also Professor for Experimental and Translational Rheumatology at the Faculty of Medicine of the University of Freiburg.

Marta Rizzi research focus is human B-lymphocytes development, maturation and activation in physiological and pathological conditions. She has developed unique expertise in in vitro modelling of early and late human B cell development.

Thomas Vogl obtained a PhD at the Graz University of Technology in Austria in the field of 'Molecular Biomedical Sciences and Biotechnology'. Having worked mostly on classical molecular biology "hands on pipetting" experiments during his initial training, he focused on bioinformatics and machine learning during postdoctoral work in Australia and Israel. Particularly in his work at the Weizmann Institute of Science he applied robotic pipelines to generate large datasets on the interplay of the human immune system and the microbiome (a summary term for all the microbes colonizing our bodies).

Since August 2022 Dr. Vogl is a group leader at the Medical University of Vienna and was awarded an assistant professorship. His work is funded by prestigious grants such as a Start Grant by the European research council, and is the coordinator of an EU funded research consortium "ID-DarkMatter-NCD" including partners from the Sorbonne in Paris, and the Karolinska institute in Sweden.